Fulcrum Therapeutics Expects $240 Million Cash Position as of December 31, 2024
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) recently provided an update on its financial situation through an updated corporate presentation published on its website on January 13, 2025. While the comprehensive financial results for the fourth quarter and fiscal year ending December 31, 2024, are yet to be finalized, the company anticipates reporting approximately $240 million in […]
More Stories
How to Eliminate Bottlenecks in Cross-Team Workflows
A business is often made of different teams. These teams need to work together. However, things don’t always go as...
Global Economy and International Trade: How the World Is Building a More Connected but Uncertain Future
The global economy is entering a new era of transformation as international trade, technological innovation and geopolitical tensions reshape relationships...
54,000 Bankruptcies Filed in October, Report Says
By Naveen Athrappully A total of 54,028 bankruptcy filings were made in October, a 2 percent jump from a year...
Trump Expects Meeting With Xi and Putin at APEC Summit in China
By Frank Fang President Donald Trump said he expects to meet Russian President Vladimir Putin and Chinese leader Xi Jinping...
Stephen Miller Responds to Being Named Chief of Staff as Deputy Steps Down
By Zachary Stieber New White House chief of staff Stephen Miller said in his first public comments since President Donald...
Nvidia Stock Slides After Chip Giant Probes CEO’s Affair With Alleged Chinese Spy
By Andrew Moran Shares of chip giant Nvidia tanked at the opening bell as the company’s board of directors opens...